Anaconda BioMed is a pre-clinical stage medical device company focused on the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke. The Company's product, ANCD Brain®, is a novel device intended to be used to restore blood flow in patients experiencing an acute ischemic stroke due to a large vessel neurovascular occlusion. The Device is indicated for thrombus removal by aspiration in intracranial arteries but it remains compatible and can be used in combination with other interventional devices.